|
Hyperthermic Intraperitoneal Chemotherapy Clinical Trials
3 actively recruiting trials across 2 locations
Also known as: HIPEC
Pipeline
Early 1: 1Phase 2: 2
Top Sponsors
- Mayo Clinic2
- Ohio State University Comprehensive Cancer Center1
Indications
- Cancer3
- Metastatic Malignant Neoplasm in the Peritoneum2
- Stage IIIB Primary Peritoneal Cancer AJCC v81
- Stage IIIB Fallopian Tube Cancer AJCC v81
- Stage IIIA2 Fallopian Tube Cancer AJCC v81
Rochester, Minnesota2 trials
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Mayo Clinic in Rochester
Phase 2
Columbus, Ohio1 trial
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
Ohio State University Comprehensive Cancer Center
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.